Clinical Trials Browser

Metastatic Castration Resistant Prostate Cancer (mCRPC) × 90 days × Clear all

NCT07621692 2026-06-02

Exploring Auger-Enhanced PSMA-Targeted Radioligand Therapy: A First-in-Taiwan Clinical Study of 161Tb-PSMA-I&T

Phase 1 Recruiting

Metastatic Castration Resistant Prostate Cancer (mCRPC)

NCT06894511 2026-05-01

PSMAndARPI

Phase 2 Active not recruiting

Metastatic Castration Resistant Prostate Cancer (mCRPC)